Sign in

CIK 0001615219

  • Non-accelerated filer
  • Smaller reporting company

Decoy Therapeutics Inc.

Sign in to watch
Ticker
DCOY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465087339
Phone
+1 346-772-0346
Business address
2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
Former names
Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 44 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-03-21 SCULLEY JOHN Director Purchase +4,000 $12.06 $48K 4,709
2016-03-21 Westphal Christoph H President and CEO Purchase +24,107 $11.70 $282K 2,887,004
2016-03-21 Westphal Christoph H President and CEO Purchase +23,951 $11.78 $282K 2,910,955
2016-03-18 SCULLEY JOHN Director Purchase +709 $11.13 $8K 709
2016-03-18 Westphal Christoph H President and CEO Purchase +18,437 $11.06 $204K 2,862,897
2016-03-17 Westphal Christoph H President and CEO Purchase +19,137 $10.94 $209K 2,844,460
2016-03-16 Westphal Christoph H President and CEO Purchase +19,142 $10.85 $208K 2,825,323
2016-03-15 Westphal Christoph H President and CEO Purchase +19,237 $9.62 $185K 2,806,181
2016-03-15 Stacy Michelle Director Purchase +2,585 $9.63 $25K 2,585
2016-03-14 Wessel Thomas Chief Medical Officer Purchase +8,000 $9.13 $73K 57,064
2016-03-11 Longwood Fund II, L.P. 10% owner Purchase +89,680 $7.00 $628K 2,786,944
2016-03-11 Westphal Christoph H President and CEO Purchase +89,680 $7.00 $628K 2,786,944
2016-03-11 Wessel Thomas Chief Medical Officer Purchase +12,000 $7.15 $86K 49,064
2016-03-11 MacKinnon Roderick Director Purchase +10,000 $7.03 $70K 431,277
2016-03-05 Stacy Michelle Director Grant or award · Stock Option (right to buy) +20,000 20,000
2016-01-21 Westphal Christoph H President and CEO Grant or award · Stock Option (right to buy) +164,000 164,000
2016-01-21 McCabe John P. VP of Finance & Treasurer Grant or award · Stock Option (right to buy) +40,000 40,000
2016-01-21 Woo Elizabeth SVP, Investor Relations Grant or award · Stock Option (right to buy) +40,000 40,000
2016-01-21 Wessel Thomas Chief Medical Officer Grant or award · Stock Option (right to buy) +52,000 52,000
2016-01-21 Lindemann Katharine Chief Operating Officer Grant or award · Stock Option (right to buy) +13,125 13,125

Page 11 of 12 · 229 trades